Literature DB >> 11685172

Subclinical hyperthyroidism as a risk factor for atrial fibrillation.

J Auer1, P Scheibner, T Mische, W Langsteger, O Eber, B Eber.   

Abstract

OBJECTIVES: Atrial fibrillation is a well-known manifestation of hyperthyroidism. We studied whether subclinical hyperthyroidism with low serum thyrotropin concentrations and free thyroid hormone concentrations within the normal range in clinically euthyroid persons is a risk factor for subsequent atrial fibrillation.
METHODS: We studied 23,638 persons. The subjects were classified according to their serum thyrotropin concentrations: group 1 comprised those with normal values of serum thyrotropin concentration (>0.4-5.0 mU/L) and free tri-iodothyronine and free thyroxine concentrations were within the normal range (22,300 subjects), group 2 comprised those with both low serum thyrotropin values (</=0.03 mU/L) and elevated free tri-iodothyronine and free thyroxine concentrations (725 subjects), and group 3 comprised those with low values of serum thyrotropin (<0.4 mU/L) and free triiodothyronine and free thyroxine concentrations were within the normal range (613 subjects).
RESULTS: Atrial fibrillation was present in 513 persons (2.3%) in group 1 with normal values for serum thyrotropin, 100 (13.8%) in group 2 with overt hyperthyroidism, and 78 (12.7%) in group 3 with subclinical hyperthyroidism. The prevalence of atrial fibrillation in patients with low serum thyrotropin concentrations (<0.4 mU/L) was 13.3% compared with 2.3% in patients with normal values for serum thyrotropin (P <.01). The relative risk of atrial fibrillation in subjects with low serum thyrotropin and normal free tri-iodothyronine and free thyroxine concentrations, compared with those with normal concentrations of serum thyrotropin, was 5.2 (95% CI 2.1-8.7, P <.01).
CONCLUSION: A low serum thyrotropin concentration is associated with a >5-fold higher likelihood for the presence of atrial fibrillation with no significant difference between subclinical and overt hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11685172     DOI: 10.1067/mhj.2001.119370

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  64 in total

1.  The metabolic consequences of thyroxine replacement in adult hypopituitary patients.

Authors:  Helena Filipsson Nyström; Ulla Feldt-Rasmussen; Ione Kourides; Vera Popovic; Maria Koltowska-Häggström; Björn Jonsson; Gudmundur Johannsson
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

Review 2.  Anterior pituitary hormone replacement therapy--a clinical review.

Authors:  Christoph J Auernhammer; George Vlotides
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

3.  AGE-RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2019-12-09

4.  P-wave dispersion in endogenous and exogenous subclinical hyperthyroidism.

Authors:  R Gen; E Akbay; A Camsari; T Ozcan
Journal:  J Endocrinol Invest       Date:  2009-07-28       Impact factor: 4.256

Review 5.  Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.

Authors:  Mark A Crandall; David J Bradley; Douglas L Packer; Samuel J Asirvatham
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

6.  How good is the levothyroxine replacement in primary hypothyroidism patients in Brazil? Data of a multicentre study.

Authors:  F Vaisman; C Medina Coeli; L S Ward; H Graf; G Carvalho; R Montenegro; M Vaisman
Journal:  J Endocrinol Invest       Date:  2013-01-14       Impact factor: 4.256

Review 7.  Thyroid, hemostasis and thrombosis.

Authors:  F Marongiu; C Cauli; S Mariotti
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

Review 8.  Subclinical hyperthyroidism: to treat or not to treat?

Authors:  E H Hoogendoorn; M den Heijer; A P J van Dijk; A R Hermus
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

9.  Thyroid Function and Dysfunction in Relation to 16 Cardiovascular Diseases.

Authors:  Susanna C Larsson; Elias Allara; Amy M Mason; Karl Michaëlsson; Stephen Burgess
Journal:  Circ Genom Precis Med       Date:  2019-03

10.  Subclinical hyperthyroidism and sport eligibility: an exploratory study on cardiovascular pre-participation screening in subjects treated with levothyroxine for multinodular goiter.

Authors:  L Di Luigi; A Parisi; F Quaranta; F Romanelli; E Tranchita; P Sgrò; P Nardi; G Fattorini; R Cavaliere; F Pigozzi; M D'Armiento; A Lenzi
Journal:  J Endocrinol Invest       Date:  2009-07-17       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.